News
- Author:
- Liam Davenport
Publish date: August 29, 2023
“Our findings are particularly promising for neuropathy since, currently, no disease-modifying treatment exists, and there are limited preventive s...
News
- Author:
- Liam Davenport
Publish date: August 29, 2023
“These findings underpin the importance of promoting healthy sleep habits to avoid sleep deprivation.”
News
- Author:
- Liam Davenport
Publish date: August 22, 2023
“Three out of the four biomarkers are already clinically and commercially available,” while the fourth, for insulin-like growth factor binding prot...
News
- Author:
- Liam Davenport
Publish date: August 14, 2023
The clinical guidelines focus on the diagnosis and management of patients with acute liver failure.
News
- Author:
- Liam Davenport
Publish date: August 2, 2023
Patients are likely to carry a dual diagnosis of liver disease and alcohol use disorder.
News
- Author:
- Liam Davenport
Publish date: July 31, 2023
These data may “help facilitate shared decision-marking and inform clinical guidelines for the treatment of such patients.”
News
- Author:
- Liam Davenport
Publish date: July 19, 2023
The imaging technique cannot be used for all patients and is currently not widely available.
News
- Author:
- Liam Davenport
Publish date: July 14, 2023
The results confirm in a “real-life setting” the efficacy and safety of the treatment.
Audio
- Author:
- Liam Davenport
Publish date: July 13, 2023
“Importantly, improving adherence and persistence represents a low-hanging fruit for increasing survival in luminal breast cancer.”
News
- Author:
- Liam Davenport
Publish date: July 12, 2023
“The burden of brain conditions will increase as populations continue to grow and age.”
News
- Author:
- Liam Davenport
Publish date: July 6, 2023
Reducing the options available to clinicians when making a differential diagnosis into the current algorithm is a pragmatic approach.
News
- Author:
- Liam Davenport
Publish date: June 22, 2023
Information from germline genetic testing could affect a patient’s cancer care.
News
- Author:
- Liam Davenport
Publish date: June 21, 2023
Despite not meeting its primary endpoint, a trial in mutated acute myeloid leukemia showed the benefit of gilteritinib maintenance in certain patie...
News
- Author:
- Liam Davenport
Publish date: June 16, 2023
Progression-free survival benefit of 1 year with venetoclax-obinutuzumab is sustained long term in chronic lymphocytic leukemia, trial analysis rev...
News
- Author:
- Liam Davenport
Publish date: June 16, 2023
“We could make the work easier to do so that you have more time with patients and less time with administrative work and have more time to process ...
